- Mount Sinai Doctors
- Accepting New Patients
Thomas B Hildebrandt, PsyD
Psychology
About Me
My research interests span three major areas: (1) development and evaluation of clinical interventions for adolescents and adults with eating and weight disorders or adults with alcohol use disorders; (2) psychiatric and physical consequences of appearance and performance enhancing drug (APED) use or anabolic androgenic steroid (AAS)use; (3) the biological basis, especially the neuroendocrine and hormonal contributions to eating and substance use disorders.
Treatment and Intervention: Currently this research involves developing novel therapeutic interventions based on exposure therapy for body image disturbances and the development of family based interventions for pediatric weight disorders, building of off the “Maudsley Method” which is a form of family therapy used to treat anorexia nervosa.
APEDs and AASs: Currently our lab is conducting the first longitudinal study of APED use among active AAS users and seeks to characterize the desirable and undesirable changes that occur in psychological domains (e.g., body image, aggression, etc.), physical domains (e.g., increases in lean muscle mass), and along the hypothalamic-pituitary-gonadal or hypothalamic-pituitary-adrenal (HPA) axes. This research seeks to identify biomarkers of AAS dependence and ultimately to develop interventions and prevention programs for APED users.
Hormones and Psychopathology: Currently our lab is interested in identifying the hormonal contributions to eating pathology, in part, to help explain the gender differences in prevalence rates of eating disorders and AAS use. Specific focuses involve the role of estrogen and other sex hormones in the adolescent onset of anorexia nervosa and the development and maintenance of bulimia nervosa.
In addition to these focuses, I have a strong interest in advanced quantitative methods including structural equation modeling, latent growth curve modeling, factor mixture modeling, and item response modeling. I teach other professionals and am interested in cognitive behavior therapy for anorexia nervosa, bulimia nervosa, eating disorder not otherwise specified, binge eating disorder across the lifespan.
Financial & Billing Information
Please direct any
detailed billing or financial inquires to the Mount Sinai Psychiatry
billing customer service number at 212-659-8752.
Language
English
Position
PROFESSOR | Psychiatry, PROFESSOR | Artificial Intelligence and Human Health
Hospital Affiliations
- The Mount Sinai Hospital
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Disease Mechanisms and Therapeutics (DMT), Neuroscience [NEU]
Clinical Focus
- Anorexia
- Drug Abuse And Drug Addiction
- Overweight/Obesity
- Psychotherapy
Video
Education
Internship, Clinical Psychology
UMDNJ-Robert Wood Johnson Medical School
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- AETNA - Commercial
- AETNA - Medicare
- Medicare - NJ
- Medicare - NY
- NJ Medicaid
- NY Medicaid
- United Health Care - Top Tier
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Hildebrandt during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Board Service
- Global Foundation for Eating Disorders
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Noom Inc. (Worksmart Labs)
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.